- Home
- PSFE vs LXEO Comparison
PSFE vs LXEO Comparison
Compare PSFE & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSFE
- LXEO
- Stock Information
- Founded
- PSFE 1996
- LXEO 2017
- Country
- PSFE United Kingdom
- LXEO United States
- Employees
- PSFE N/A
- LXEO N/A
- Industry
- PSFE Business Services
- LXEO
- Sector
- PSFE Consumer Discretionary
- LXEO
- Exchange
- PSFE Nasdaq
- LXEO Nasdaq
- Market Cap
- PSFE 599.1M
- LXEO 597.8M
- IPO Year
- PSFE N/A
- LXEO 2023
- Fundamental
- Price
- PSFE $7.38
- LXEO $9.08
- Analyst Decision
- PSFE Sell
- LXEO Strong Buy
- Analyst Count
- PSFE 4
- LXEO 8
- Target Price
- PSFE $17.38
- LXEO $18.13
- AVG Volume (30 Days)
- PSFE 427.8K
- LXEO 1.5M
- Earning Date
- PSFE 11-13-2025
- LXEO 11-05-2025
- Dividend Yield
- PSFE N/A
- LXEO N/A
- EPS Growth
- PSFE N/A
- LXEO N/A
- EPS
- PSFE N/A
- LXEO N/A
- Revenue
- PSFE $1,683,103,000.00
- LXEO N/A
- Revenue This Year
- PSFE $3.24
- LXEO N/A
- Revenue Next Year
- PSFE $7.10
- LXEO N/A
- P/E Ratio
- PSFE N/A
- LXEO N/A
- Revenue Growth
- PSFE N/A
- LXEO N/A
- 52 Week Low
- PSFE $7.29
- LXEO $1.45
- 52 Week High
- PSFE $24.11
- LXEO $11.72
- Technical
- Relative Strength Index (RSI)
- PSFE 18.47
- LXEO 54.59
- Support Level
- PSFE $9.95
- LXEO $7.66
- Resistance Level
- PSFE $10.81
- LXEO $9.63
- Average True Range (ATR)
- PSFE 0.51
- LXEO 0.67
- MACD
- PSFE -0.24
- LXEO -0.14
- Stochastic Oscillator
- PSFE 0.18
- LXEO 48.53
About PSFE Paysafe Limited
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.